Janssen Pharmaceutica NV
Beerse, Belgium
Purpose
to validate bedaquiline provisional breakpoints in order to support the WHO policy recommendations for the Bedaquiline Treatment Guideline for multidrug resistant tuberculosis
Division
Global Health
Date
October 2017
Region Served
GLOBAL
Committed amount
$230,000
Grant topic
Tuberculosis
Duration (months)
15
Grantee location
Beerse, Belgium
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.